Article
Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Genetic testing and molecular biomarkers - 1 Apr 2016
Wang Xu-Cai, Wang Fan, Quan Qing-Qing
Abstract excerpt
OBJECTIVE: To investigate the potential prognostic roles of polymorphisms in the X-ray repair cross-complementing group 1 (XPCC1), xeroderma pigmentosum group D (XPD) and excision repair cross-complementing group 1 (ERCC1) genes for patients with hepatocellular carcinoma (HCC) receiving transcatheter arterial chemoembolization (TACE). METHODS: Clinical data and blood samples from 308 HCC patients receiving TACE...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
